Clinical Trial Update: Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AZD7798 for treatment in Crohn's disease patients with an ileostomy; recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• AZD7798 (AZD7798)

Snippet

Sponsor: AstraZeneca | Conditions: Crohn's Disease | Phase 2 | Status: RECRUITING